BLFS Q1 2024 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$18M-51.1% YoY

Gross Profit

$12M66.4% margin

Operating Income

-$3M-17.9% margin

Net Income

-$10M-55.4% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$402M

Total Liabilities

$68M

Stockholders' Equity

$333M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$38M	-51.1%
Gross Profit	$12M	$14M	-12.8%
Operating Income	-$3M	-$13M	+74.4%
Net Income	-$10M	-$14M	+25.5%

Revenue Segments

Product

$25M44%

Product, Cell Processing

$16M29%

Product, Freezer and Thaw

$8M15%

Service

$5M9%

Rental Revenue

$2M3%